Audio long read: Long COVID is a double curse in low-income nations — here's why

Heidi Ledford,Benjamin Thompson

DOI: https://doi.org/10.1038/d41586-024-00224-3

IF: 64.8

2024-01-27

Nature

Abstract:A dearth of research means the condition is often ignored by physicians. Listen to an audio version of a recent Nature Feature.

multidisciplinary sciences

What problem does this paper attempt to address?

Audio long read: Why loneliness is bad for your health

Saima May Sidik,Benjamin Thompson

DOI: https://doi.org/10.1038/d41586-024-01251-w

IF: 64.8

2024-04-27

Nature

Abstract:New research is revealing the mechanisms linking loneliness and conditions like dementia, depression and cardiovascular disease. Listen to an audio version of a recent Nature Feature.

multidisciplinary sciences
Long covid—mechanisms, risk factors, and management

Harry Crook,Sanara Raza,Joseph Nowell,Megan Young,Paul Edison

DOI: https://doi.org/10.1136/bmj.n1648

2021-07-26

BMJ

Abstract:Abstract Since its emergence in Wuhan, China, covid-19 has spread and had a profound effect on the lives and health of people around the globe. As of 4 July 2021, more than 183 million confirmed cases of covid-19 had been recorded worldwide, and 3.97 million deaths. Recent evidence has shown that a range of persistent symptoms can remain long after the acute SARS-CoV-2 infection, and this condition is now coined long covid by recognized research institutes. Studies have shown that long covid can affect the whole spectrum of people with covid-19, from those with very mild acute disease to the most severe forms. Like acute covid-19, long covid can involve multiple organs and can affect many systems including, but not limited to, the respiratory, cardiovascular, neurological, gastrointestinal, and musculoskeletal systems. The symptoms of long covid include fatigue, dyspnea, cardiac abnormalities, cognitive impairment, sleep disturbances, symptoms of post-traumatic stress disorder, muscle pain, concentration problems, and headache. This review summarizes studies of the long term effects of covid-19 in hospitalized and non-hospitalized patients and describes the persistent symptoms they endure. Risk factors for acute covid-19 and long covid and possible therapeutic options are also discussed.
Long COVID research in minority ethnic populations may be lost in translation

Kamlesh Khunti,Amitava Banerjee,Rachael A. Evans,Melanie Calvert

DOI: https://doi.org/10.1038/s41591-024-03070-y

IF: 82.9

2024-06-26

Nature Medicine

Abstract:SARS-CoV-2 infection can lead to multiorgan systemic damage and prolonged symptoms over many weeks and months, a condition known as long COVID or post-COVID syndrome or condition. Certain populations, such as older people, those with chronic comorbidities and severe infections, socioeconomically deprived populations, and minority ethnic populations, have been disproportionately affected by acute COVID-19. A plethora of studies into long COVID have been published over the past three years, including several systematic reviews. However, data on long COVID in minority ethnic groups and across intersectional analysis are lacking. Where data have been reported, inconsistent estimates for the prevalence of long COVID have been reported. Furthermore, most published data are from high-income countries, that either fail to report demographic information or are not representative of the general population. Data from low-income countries for comparison of long COVID rates and symptoms are lacking. One large UK analysis of ten longitudinal studies reported that overall odds of long COVID symptoms lasting more than four weeks was significantly lower in south Asian and Black populations compared to white populations 1 . By contrast, a large Danish nationwide cohort study using routine data suggested that people from minority ethnic groups from North Africa, Middle East, Eastern Europe and Asia had significantly greater risk of long COVID compared to 'native Danes' (participants originating and/or born in Denmark) 2 .

biochemistry & molecular biology,cell biology,medicine, research & experimental
Attributes and predictors of long COVID

Carole H. Sudre,Benjamin Murray,Thomas Varsavsky,Mark S. Graham,Rose S. Penfold,Ruth C. Bowyer,Joan Capdevila Pujol,Kerstin Klaser,Michela Antonelli,Liane S. Canas,Erika Molteni,Marc Modat,M. Jorge Cardoso,Anna May,Sajaysurya Ganesh,Richard Davies,Long H. Nguyen,David A. Drew,Christina M. Astley,Amit D. Joshi,Jordi Merino,Neli Tsereteli,Tove Fall,Maria F. Gomez,Emma L. Duncan,Cristina Menni,Frances M. K. Williams,Paul W. Franks,Andrew T. Chan,Jonathan Wolf,Sebastien Ourselin,Tim Spector,Claire J. Steves

DOI: https://doi.org/10.1038/s41591-021-01292-y

IF: 82.9

2021-03-10

Nature Medicine

Abstract:Reports of long-lasting coronavirus disease 2019 (COVID-19) symptoms, the so-called 'long COVID', are rising but little is known about prevalence, risk factors or whether it is possible to predict a protracted course early in the disease. We analyzed data from 4,182 incident cases of COVID-19 in which individuals self-reported their symptoms prospectively in the COVID Symptom Study app<sup><a href="/articles/s41591-021-01292-y#ref-CR1">1</a></sup>. A total of 558 (13.3%) participants reported symptoms lasting ≥28 days, 189 (4.5%) for ≥8 weeks and 95 (2.3%) for ≥12 weeks. Long COVID was characterized by symptoms of fatigue, headache, dyspnea and anosmia and was more likely with increasing age and body mass index and female sex. Experiencing more than five symptoms during the first week of illness was associated with long COVID (odds ratio = 3.53 (2.76–4.50)). A simple model to distinguish between short COVID and long COVID at 7 days (total sample size, <i>n</i> = 2,149) showed an area under the curve of the receiver operating characteristic curve of 76%, with replication in an independent sample of 2,472 individuals who were positive for severe acute respiratory syndrome coronavirus 2. This model could be used to identify individuals at risk of long COVID for trials of prevention or treatment and to plan education and rehabilitation services.

biochemistry & molecular biology,cell biology,medicine, research & experimental
Prevalence of Long-COVID Among Low-Income and Marginalized Groups: Evidence From Israel

Oren Heller,Yung Chun,Stav Shapira,Aron Troen,Yaniv Shlomo,Mary Acri,Phillip Marotta,Saneel Kulkarni,Brendan Kinnison,Michal Grinstein-Weiss

DOI: https://doi.org/10.3389/ijph.2022.1605086

2022-11-28

International Journal of Public Health

Abstract:Objective: To identify the socioeconomic and demographic factors associated with the prevalence of self-reported long-COVID symptoms. Method: We examined the association between acute-COVID (SARS-CoV-2) and long-COVID symptoms, by a cross-sectional analysis of data obtained on a prospective online-survey, conducted from November to December 2021 on a nationally-representative sample of the Israeli population (N = 2,246). Results: Findings suggest that there is a greater likelihood of experiencing long-COVID symptoms among low-income and among marginalized groups. After controlling for demographic and socioeconomic attributes, those who had moderate/severe acute-COVID were 1.3 ( p < 0.05) times more likely to experience a long-term symptom and also reported more long-term symptoms (2.2 symptoms) than those who have not been infected (1.4 symptoms; p < 0.01). Among the low-income group, a larger gap in symptom count was found between those who had moderate/severe acute-COVID (3.3 symptoms) and those who had not been infected (1.8 symptoms, p < 0.05). Conclusion: Our findings highlight the importance of raising awareness of long-COVID among marginalized population groups, and to the therapeutic options available. Such efforts should be tailored and should consider the unique socioeconomic and cultural characteristics, as well as the preexisting low access to healthcare services among these groups.

public, environmental & occupational health
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Hannah E. Davis,Gina S. Assaf,Lisa McCorkell,Hannah Wei,Ryan J. Low,Yochai Re'em,Signe Redfield,Jared P. Austin,Athena Akrami

DOI: https://doi.org/10.1016/j.eclinm.2021.101019

IF: 15.1

2021-08-01

EClinicalMedicine

Abstract:BackgroundA significant number of patients with COVID-19 experience prolonged symptoms, known as Long COVID. Few systematic studies have investigated this population, particularly in outpatient settings. Hence, relatively little is known about symptom makeup and severity, expected clinical course, impact on daily functioning, and return to baseline health.MethodsWe conducted an online survey of people with suspected and confirmed COVID-19, distributed via COVID-19 support groups (e.g. Body Politic, Long COVID Support Group, Long Haul COVID Fighters) and social media (e.g. Twitter, Facebook). Data were collected from September 6, 2020 to November 25, 2020. We analyzed responses from 3762 participants with confirmed (diagnostic/antibody positive; 1020) or suspected (diagnostic/antibody negative or untested; 2742) COVID-19, from 56 countries, with illness lasting over 28 days and onset prior to June 2020. We estimated the prevalence of 203 symptoms in 10 organ systems and traced 66 symptoms over seven months. We measured the impact on life, work, and return to baseline health.FindingsFor the majority of respondents (>91%), the time to recovery exceeded 35 weeks. During their illness, participants experienced an average of 55.9+/- 25.5 (mean+/-STD) symptoms, across an average of 9.1 organ systems. The most frequent symptoms after month 6 were fatigue, post-exertional malaise, and cognitive dysfunction. Symptoms varied in their prevalence over time, and we identified three symptom clusters, each with a characteristic temporal profile. 85.9% of participants (95% CI, 84.8% to 87.0%) experienced relapses, primarily triggered by exercise, physical or mental activity, and stress. 86.7% (85.6% to 92.5%) of unrecovered respondents were experiencing fatigue at the time of survey, compared to 44.7% (38.5% to 50.5%) of recovered respondents. 1700 respondents (45.2%) required a reduced work schedule compared to pre-illness, and an additional 839 (22.3%) were not working at the time of survey due to illness. Cognitive dysfunction or memory issues were common across all age groups (~88%). Except for loss of smell and taste, the prevalence and trajectory of all symptoms were similar between groups with confirmed and suspected COVID-19.InterpretationPatients with Long COVID report prolonged, multisystem involvement and significant disability. By seven months, many patients have not yet recovered (mainly from systemic and neurological/cognitive symptoms), have not returned to previous levels of work, and continue to experience significant symptom burden.FundingAll authors contributed to this work in a voluntary capacity. The cost of survey hosting (on Qualtrics) and publication fee was covered by AA's research grant (Wellcome Trust/Gatsby Charity via Sainsbury Wellcome center, UCL).
Long-Term Effects of COVID-19: The Stories of 2 Physicians Who Became Patients

James Mwangi,Jeffrey N Siegelman

2024-04-18

Abstract:Approximately 10% of patients who survive COVID-19 will proceed to have lasting, often debilitating effects, known as "long COVID." These symptoms can take various forms, most commonly including postexertional malaise, fatigue, brain fog, dizziness, gastrointestinal symptoms, heart palpitations, diminished sexual desire or capacity, loss of smell or taste, thirst, chronic cough, chest pain, and abnormal movements. Here, 2 physician-patients present their own experiences with long COVID and share their perspectives on the experience. One key insight is that patients who are not familiar with long COVID may not attribute ongoing symptoms to their illness. Diagnosis requires an astute, compassionate physician who understands long COVID and can appropriately situate the symptoms within the evolving understanding of the condition, leading the patient toward recovery.
Long Covid: a global health issue - a prospective, cohort study set in four continents

Ekaterina Pazukhina,Esteban Garcia-Gallo,Luis Felipe Reyes,Anders Benjamin Kildal,Waasila Jassat,Murray Dryden,Jan Cato Holter,Allegra Chatterjee,Kyle Gomez,Arne Søraas,Matteo Puntoni,Nicola Latronico,Fernando A Bozza,Michael Edelstein,Bronner P Gonçalves,Christiana Kartsonaki,Oksana Kruglova,Sérgio Gaião,Yock Ping Chow,Yash Doshi,Sara Isabel Duque Vallejo,Elsa D Ibáñez-Prada,Yuli V Fuentes,Claire Hastie,Margaret E O'Hara,Valeria Balan,Tigist Menkir,Laura Merson,Sadie Kelly,Barbara Wanjiru Citarella,Malcolm G Semple,Janet T Scott,Daniel Munblit,Louise Sigfrid,ISARIC Clinical Characterisation Group and ISARIC Global Covid-19 follow up working group

DOI: https://doi.org/10.1136/bmjgh-2024-015245

2024-10-21

Abstract:Introduction: A proportion of people develop Long Covid after acute COVID-19, but with most studies concentrated in high-income countries (HICs), the global burden is largely unknown. Our study aims to characterise long-term COVID-19 sequelae in populations globally and compare the prevalence of reported symptoms in HICs and low-income and middle-income countries (LMICs). Methods: A prospective, observational study in 17 countries in Africa, Asia, Europe and South America, including adults with confirmed COVID-19 assessed at 2 to <6 and 6 to <12 months post-hospital discharge. A standardised case report form developed by International Severe Acute Respiratory and emerging Infection Consortium's Global COVID-19 Follow-up working group evaluated the frequency of fever, persistent symptoms, breathlessness (MRC dyspnoea scale), fatigue and impact on daily activities. Results: Of 11 860 participants (median age: 52 (IQR: 41-62) years; 52.1% females), 56.5% were from HICs and 43.5% were from LMICs. The proportion identified with Long Covid was significantly higher in HICs vs LMICs at both assessment time points (69.0% vs 45.3%, p<0.001; 69.7% vs 42.4%, p<0.001). Participants in HICs were more likely to report not feeling fully recovered (54.3% vs 18.0%, p<0.001; 56.8% vs 40.1%, p<0.001), fatigue (42.9% vs 27.9%, p<0.001; 41.6% vs 27.9%, p<0.001), new/persistent fever (19.6% vs 2.1%, p<0.001; 20.3% vs 2.0%, p<0.001) and have a higher prevalence of anxiety/depression and impact on usual activities compared with participants in LMICs at 2 to <6 and 6 to <12 months post-COVID-19 hospital discharge, respectively. Conclusion: Our data show that Long Covid affects populations globally, manifesting similar symptomatology and impact on functioning in both HIC and LMICs. The prevalence was higher in HICs versus LMICs. Although we identified a lower prevalence, the impact of Long Covid may be greater in LMICs if there is a lack of support systems available in HICs. Further research into the aetiology of Long Covid and the burden in LMICs is critical to implement effective, accessible treatment and support strategies to improve COVID-19 outcomes for all.
The double invisibility of long Covid in children

Cervantée Wild,Alice MacLean,Sarah Nettleton,Kate Hunt,Sue Ziebland

DOI: https://doi.org/10.1016/j.socscimed.2024.116770

IF: 5.379

2024-03-16

Social Science & Medicine

Abstract:The Covid-19 pandemic has been dominated by discussions of mild and short-lasting cases or acutely serious or lethal forms of the disease; less attention has been paid to long-term Covid-19 symptoms ('Long Covid'), particularly in children. This analysis of the experiences of children and adolescents with Long Covid, and those of their parents/caregivers, argues that children with Long Covid encounter a 'double invisibility' due to the condition's limited social currency and their status as the youngest members of society. We draw on 39 narrative interviews about children's and adolescents' experiences, conducted in 2021–2022 in the United Kingdom. The occurrence of Long Covid in children challenges key aspects of a dominant pandemic narrative, some of which have persisted from the early stages of the pandemic into 2023. Analysis of our qualitative interviews demonstrates that participant experiences were shaped and undermined by the convergence of three elements of the dominant pandemic narrative: that Covid-19 is mild, and everyone recovers; that children are not badly affected by Covid-19; and that worst of the pandemic was essentially 'over' as early as 2021/2022. In the face of these characterisations of Covid-19 experience, young people and their families reported significant additional challenges in making the illness experiences of children and adolescents visible, and thus in gaining appropriate support from medical and educational professionals. We interpret this in relation to 'social currency' - the extent to which an illness elicits understanding and acceptance by wider society. Children and adolescents with Long Covid struggled to signal the severity of their condition and elicit care in the manner expected for other debilitating illnesses. This was exacerbated by assumptions and stereotypes about unwell children and adolescents, and their parents, and questioning of their candidacy as reliable, trustworthy patients.

public, environmental & occupational health,social sciences, biomedical
Long Covid: Online patient narratives, public health communication and vaccine hesitancy

Esperanza Miyake,Sam Martin

DOI: https://doi.org/10.1177/20552076211059649

2021-01-01

Digital Health

Abstract:Introduction This study combines quantitative and qualitative analyses of social media data collected through three key stages of the pandemic, to highlight the following: ‘First wave’ (March to May, 2020): negative consequences arising from a disconnect between official health communications, and unofficial Long Covid sufferers’ narratives online. ‘Second wave’ (October 2020 to January 2021): closing the ‘gap’ between official health communications and unofficial patient narratives, leading to a better integration between patient voice, research and services. ‘Vaccination phase’ (January 2021, early stages of the vaccination programme in the UK): continuing and new emerging concerns. Methods We adopted a mixed methods approach involving quantitative and qualitative analyses of 1.38 million posts mentioning long-term symptoms of Covid-19, gathered across social media and news platforms between 1 January 2020 and 1 January 2021, on Twitter, Facebook, Blogs, and Forums. Our inductive thematic analysis was informed by our discourse analysis of words, and sentiment analysis of hashtags and emojis. Results Results indicate that the negative impacts arise mostly from conflicting definitions of Covid-19 and fears around the Covid-19 vaccine for Long Covid sufferers. Key areas of concern are: time/duration; symptoms/testing; emotional impact; lack of support and resources. Conclusions Whilst Covid-19 is a global issue, specific sociocultural, political and economic contexts mean patients experience Long Covid at a localised level, needing appropriate localised responses. This can only happen if we build a knowledge base that begins with the patient, ultimately informing treatment and rehabilitation strategies for Long Covid.
Pathophysiological, immunological, and inflammatory features of long COVID

Karen Bohmwald,Benjamín Diethelm-Varela,Linmar Rodríguez-Guilarte,Thomas Rivera,Claudia A. Riedel,Pablo A. González,Alexis M. Kalergis

DOI: https://doi.org/10.3389/fimmu.2024.1341600

IF: 7.3

2024-02-29

Frontiers in Immunology

Abstract:The COVID-19 pandemic continues to cause severe global disruption, resulting in significant excess mortality, overwhelming healthcare systems, and imposing substantial social and economic burdens on nations. While most of the attention and therapeutic efforts have concentrated on the acute phase of the disease, a notable proportion of survivors experience persistent symptoms post-infection clearance. This diverse set of symptoms, loosely categorized as long COVID, presents a potential additional public health crisis. It is estimated that 1 in 5 COVID-19 survivors exhibit clinical manifestations consistent with long COVID. Despite this prevalence, the mechanisms and pathophysiology of long COVID remain poorly understood. Alarmingly, evidence suggests that a significant proportion of cases within this clinical condition develop debilitating or disabling symptoms. Hence, urgent priority should be given to further studies on this condition to equip global public health systems for its management. This review provides an overview of available information on this emerging clinical condition, focusing on the affected individuals' epidemiology, pathophysiological mechanisms, and immunological and inflammatory profiles.

immunology
The long COVID research literature

Alan L. Porter,Mark Markley,Nils Newman

DOI: https://doi.org/10.3389/frma.2023.1149091

2023-03-24

Frontiers in Research Metrics and Analytics

Abstract:While the COVID-19 pandemic morphs into less malignant forms, the virus has spawned a series of poorly understood, post-infection symptoms with staggering ramifications, i. e., long COVID (LC). This bibliometric study profiles the rapidly growing LC research domain [5,243 articles from PubMed and Web of Science (WoS)] to make its knowledge content more accessible. The article addresses What? Where? Who? and When? questions. A 13-topic Concept Grid presents bottom-up topic clusters. We break out those topics with other data fields, including disciplinary concentrations, topical details, and information on research “players” (countries, institutions, and authors) engaging in those topics. We provide access to results via a Dashboard website. We find a strongly growing, multidisciplinary LC research domain. That domain appears tightly connected based on shared research knowledge. However, we also observe notable concentrations of research activity in different disciplines. Data trends over 3 years of LC research suggest heightened attention to psychological and neurodegenerative symptoms, fatigue, and pulmonary involvement.
Long COVID Illness: Disparities in Understanding and Receipt of Care in Emergency Department Populations

Robert M Rodriguez,Karen Reyes,Vijaya Arun Kumar,Brian Chinnock,Stephanie A Eucker,Kristin L Rising,Zubaid Rafique,Michael Gottlieb,Graham Nichol,Dana Morse,Melanie Molina,Mireya I Arreguin,Lindsey Shughart,Christopher Conn,Svea Eckstrand,Heba Mesbah,Lauren Chakraborty,Robert D Welch

DOI: https://doi.org/10.1016/j.annemergmed.2024.07.009

2024-09-24

Abstract:Study objective: Most long coronavirus disease (long COVID) studies rely on traditional surveillance methods that miss underserved populations who use emergency departments (EDs) as their primary health care source. In medically underserved ED populations, we sought to determine (1) whether there are gaps in awareness and self-declared understanding about long COVID illness, and (2) the prevalence, impact on school/work attendance, and receipt of care for long COVID symptoms. Methods: This study was a cross-sectional, convenience sample survey study of adult patients at 11 geographically representative US EDs from December 2022 to October 2023. Awareness and self-declared understanding about long COVID illness were measured. Prevalence, impact on school/work attendance, and receipt of care for long COVID symptoms were also assessed. Results: Of 1,618 eligible patients, 1455 (89.9%) agreed to participate, including 33.4% African Americans and 30.9% Latino/a. Of the patients, 17.1% lacked primary care. In total, 33.2% had persistent COVID-19 symptoms lasting >1 month, and 20.3% had symptoms >3 months. Moreover, 49.8% with long COVID symptoms missed work/school because of symptoms; 30.3% of all participants and 33.5% of participants who had long COVID symptoms had prior awareness and self-declared understanding of long COVID. Characteristics associated with poor understanding of long COVID were African American race (adjusted odds ratio [aOR] 3.68, 95% confidence interval [CI] 2.66 to 5.09) and Latino/a ethnicity (aOR 3.16, 95% CI 2.15 to 4.64). Participants lacking primary care were less likely to have received long COVID care (24.6% versus 51.2%; difference 26.6%; 95% CI 13.7% to 36.9%). Conclusions: Despite high prevalence and impact on school/work attendance of long COVID symptoms, most of this ED population had limited awareness and self-declared understanding of long COVID, and many had not received care. EDs should consider the development of protocols for diagnosis, education, and treatment of long COVID illness.
Epidemiological and clinical perspectives of long COVID syndrome

Katherine Huerne,Kristian B Filion,Roland Grad,Pierre Ernst,Andrea S Gershon,Mark J Eisenberg

DOI: https://doi.org/10.1016/j.ajmo.2023.100033

Abstract:Long COVID, or post-acute COVID-19 syndrome, is characterized by multi-organ symptoms lasting 2+ months after initial COVID-19 virus infection. This review presents the current state of evidence for long COVID syndrome, including the global public health context, incidence, prevalence, cardiopulmonary sequelae, physical and mental symptoms, recovery time, prognosis, risk factors, rehospitalization rates, and the impact of vaccination on long COVID outcomes. Results are presented by clinically relevant subgroups. Overall, 10-35% of COVID survivors develop long COVID, with common symptoms including fatigue, dyspnea, chest pain, cough, depression, anxiety, post-traumatic stress disorder, memory loss, and difficulty concentrating. Delineating these issues will be crucial to inform appropriate post-pandemic health policy and protect the health of COVID-19 survivors, including potentially vulnerable or underrepresented groups. Directed to policymakers, health practitioners, and the general public, we provide recommendations and suggest avenues for future research with the larger goal of reducing harms associated with long COVID syndrome.
A Comprehensive Review of the Global Epidemiology, Clinical Management, Socio-Economic Impacts, and National Responses to Long COVID with Future Research Directions

Xiufang Song,Weiwei Song,Lizhen Cui,Tim Q. Duong,Rajiv Pandy,Hongdou Liu,Qun Zhou,Jiayao Sun,Yanli Liu,Tong Li

DOI: https://doi.org/10.3390/diagnostics14111168

IF: 3.6

2024-06-01

Diagnostics

Abstract:Background: Long COVID, characterized by a persistent symptom spectrum following SARS-CoV-2 infection, poses significant health, social, and economic challenges. This review aims to consolidate knowledge on its epidemiology, clinical features, and underlying mechanisms to guide global responses; Methods: We conducted a literature review, analyzing peer-reviewed articles and reports to gather comprehensive data on long COVID's epidemiology, symptomatology, and management approaches; Results: Our analysis revealed a wide array of long COVID symptoms and risk factors, with notable demographic variability. The current understanding of its pathophysiology suggests a multifactorial origin yet remains partially understood. Emerging diagnostic criteria and potential therapeutic strategies were identified, highlighting advancements in long COVID management; Conclusions: This review highlights the multifaceted nature of long COVID, revealing a broad spectrum of symptoms, diverse risk factors, and the complex interplay of physiological mechanisms underpinning the condition. Long COVID symptoms and disorders will continue to weigh on healthcare systems in years to come. Addressing long COVID requires a holistic management strategy that integrates clinical care, social support, and policy initiatives. The findings underscore the need for increased international cooperation in research and health planning to address the complex challenges of long COVID. There is a call for continued refinement of diagnostic and treatment modalities, emphasizing a multidisciplinary approach to manage the ongoing and evolving impacts of the condition.

medicine, general & internal
Insights into Long COVID: Unraveling Risk Factors, Clinical Features, Radiological Findings, Functional Sequelae and Correlations: A Retrospective Cohort Study

Patrizia Pasculli,Maria Antonella Zingaropoli,Federica Dominelli,Angelo Giuseppe Solimini,Giorgio Maria Masci,Lucia Ilaria Birtolo,Lara Pasquariello,Filippo Paribeni,Franco Iafrate,Valeria Panebianco,Gioacchino Galardo,Massimo Mancone,Carlo Catalano,Francesco Pugliese,Paolo Palange,Claudio Maria Mastroianni,Maria Rosa Ciardi

DOI: https://doi.org/10.1016/j.amjmed.2024.09.006

2024-09-18

Abstract:Background: The long-term symptomatology of COVID-19 has yet to be comprehensively described. The aim of the study was to describe persistent COVID-19 symptoms in a cohort of hospitalized and home-isolated patients. Methods: A retrospective cohort study was conducted on long COVID patients. Long COVID symptoms were identified, and patients were divided into hospitalized (in-patients) and home-isolated (out-patients), as well as according to the number of symptoms. Patients were examined by a multidisciplinary medical team. Blood tests, high resolution chest computed tomography (CT), and physical and infectious examinations were performed. Finally, in-patients were evaluated at 2 time-points: on hospital admission (T0) and 3 months after discharge (Tpost). Results: There were 364 COVID-19 patients enrolled; 82% of patients reported one or more symptoms. The most reported symptom was fatigue. Chest CT showed alteration in 76% of patients, and pulmonary function alterations were observed in 44.7% of patients. A higher risk of presenting at least one symptom was seen in patients treated with corticosteroid, and a higher risk of presenting chest CT residual lesion was observed in hospitalized patients and in patients that received hydroxychloroquine treatment. Moreover, a higher risk of altered pulmonary function was observed in older patients. Conclusion: Long-term sequelae are present in a remarkable number of long COVID patients and pose a new challenge to the health care system to identify long-lasting effects and improve patients' well-being. Multidisciplinary teams are crucial to develop preventive measures, and clinical management strategies.
Diagnosing, Managing, and Studying Long-COVID Syndromes in Children & Adolescents in Rural and Underserved Populations

Kathryn Weakley,Jessica Snowden

DOI: https://doi.org/10.1016/j.anai.2024.08.028

2024-08-24

Abstract:The COVID-19 pandemic has arguably had its greatest impact in rural and other historically hard-to-reach populations. Families in rural and underserved communities experienced COVID-19 infections at higher rate than their peers in other groups and also experienced disproportionate morbidity and mortality. Without careful design and implementation of resources, children in these areas are also at risk of being disproportionately impacted by long-term sequelae of SARS-CoV-2 infections, such as "Long COVID" syndromes. Increased frequency and severity of COVID-19 infections; decreased access to healthcare and supporting services; environmental and social structure factors that exacerbate post-acute sequelae of COVID-19 (PASC); and increased baseline frequency of health disorders that may complicate post-COVID issues, such as higher rates of obesity, asthma, diabetes, and mental health disorders all place children and adolescents in under-resourced areas at significant risk. Unfortunately, children and adolescents in these areas have been historically underrepresented in clinical research. Not only are fewer studies published with participants in rural and underserved communities, but these studies more often exhibit lower quality with fewer randomized controlled trials and multicenter studies. This gap not only deprives people in rural and underserved areas of the country of access to cutting edge therapy; but it also risks "evidence-based" solutions that are not generalizable because they cannot be implemented in the areas disproportionately impacted by many health conditions such as Long COVID. These factors significantly impede our ability to provide appropriate medical care for underserved communities. This review will discuss the impact of COVID-19 in rural and underserved communities and the factors that must be considered in designing evidence-based Long COVID solutions for children and adolescents in these areas.
Disparities by social determinants of health: links between Long COVID and cardiovascular disease.

Amitava Banerjee

DOI: https://doi.org/10.1016/j.cjca.2024.02.017

IF: 6.614

2024-02-01

Canadian Journal of Cardiology

Abstract:Long COVID has been defined by World Health Organization as "continuation or development of new symptoms 3 months after the initial SARS-CoV-2 infection, with these symptoms lasting for at least 2 months with no other explanation". Cardiovascular disease is implicated as a risk factor, concomitant condition and consequence of Long COVID. As well as heterogeneity in definition, presentation and likely underlying pathophysiology of Long COVID, disparities by social determinants of health, extensively studied and described in cardiovascular disease, have been observed in three ways. First, underlying long-term conditions, such as cardiovascular disease and its risk factors, are associated with incidence and severity of Long COVID, and previously described socioeconomic disparities in these factors are important in exacerbating disparities in Long COVID. Second, socioeconomic disparities in management of COVID-19 may themselves lead to distal disparities in Long COVID. Third, there are socioeconomic disparities in the way that Long COVID is diagnosed, managed and prevented. Together, factors such as age, sex, deprivation and ethnicity have far-reaching implications in this new post-viral syndrome across its management spectrum. There are similarities and differences compared with disparities for cardiovascular disease. Some of these disparities are in fact, inequalities, i.e. rather than simply observed variations, they represent injustices with costs to individuals, communities and economies. In this review of current literature, I consider opportunities to prevent, or at least, attenuate these socioeconomic disparities in Long COVID and cardiovascular disease, with special challenges for research, clinical practice, public health and policy in a new disease which is evolving.

cardiac & cardiovascular systems
Understanding Health Disparities and Economic Implications in Long COVID Worldwide

Jaleel Jerry G. Sweis,Fatima Alnaimat,Valeria Esparza,Supritha Prasad,Abeera Azam,Zeel Modi,Mina Al-Awqati,Pim Jetanalin,Nadia J. Sweis,Christian Ascoli,Richard M. Novak,Israel Rubinstein,Ilias C. Papanikolaou,Nadera Sweiss

DOI: https://doi.org/10.3390/ijerph21030325

IF: 4.614

2024-03-12

International Journal of Environmental Research and Public Health

Abstract:The COVID-19 pandemic has resulted in a growing number of patients experiencing persistent symptoms and physiological changes after recovering from acute SARS-CoV-2 infection, known as Long COVID. Long COVID is characterized by recurring symptoms and inflammation across multiple organ systems. Diagnosis can be challenging, influenced by factors like demographics, comorbidities, and immune responses. Long COVID impacts various organ systems and can have neuropsychological effects. Health disparities, particularly related to race, contribute to a higher burden of infection and ongoing symptoms in minority populations. Managing Long COVID entails addressing a spectrum of symptoms that encompass physical, cognitive, and psychological aspects. The recovery period for patients with Long COVID can vary significantly, influenced by factors like the severity of the disease, hospitalization, comorbidities, and age. Currently, there are no universally effective treatments, although certain interventions show promise, necessitating further research. Self-management and rehabilitation programs can provide relief, but more research is needed to establish their effectiveness. Preventive measures such as vaccination and the use of antiviral medications and metformin. It is imperative to conduct further research to develop evidence-based guidelines and gain a better understanding of the long-term implications of COVID-19. Long COVID could have substantial economic impact on the labor market, productivity, healthcare expenditures, and overall economic growth. To address the challenges patients with long-term complications face, there is a focus on strategies like promoting telework and flexible work arrangements to accommodate diverse symptoms, particularly chronic fatigue and other Long COVID effects. In conclusion, this review emphasizes the multifaceted complexity of Long COVID and the ongoing need to address its potential long-term health and economic impacts.

public, environmental & occupational health,environmental sciences
Long-COVID improves in 50% of patients after a year in a Midwestern cohort

Grant Stalker,Rosarie Tudas,Alpana Garg,Lauren Graham,Andrew L Thurman,R Todd Wiblin,Nabeel Hamzeh,Robert J Blount,Raul Villacreses,Joseph Zabner,Alejandro Comellas,Josalyn L Cho,Alejandro Pezzulo

DOI: https://doi.org/10.1101/2024.04.30.24306497

2024-05-01

MedRxiv

Abstract:Background: Many of those infected with COVID-19 experience long-term disability due to persistent symptoms known as Long-COVID, which include ongoing respiratory issues, loss of taste and smell, and impaired daily functioning. Research question: This study aims to better understand the chronology of long-COVID symptoms. Study design and methods: We prospectively enrolled 403 adults from the University of Iowa long-COVID clinic (June 2020 to February 2022). Participants provided symptom data during acute illness, symptom progression, and other clinical characteristics. Patients in this registry received a survey containing questions including current symptoms and status since long-COVID diagnosis (sliding status scale, PHQ2, GAD2, MMRC). Those >12 months since acute-COVID diagnosis had chart review done to track their symptomology. Results: Of 403 participants contacted, 129 (32%) responded. The mean age (in years) was 50.17 +/-14.28, with 31.8% male and 68.2% female. Severity of acute covid treatment was stratified by treatment in the outpatient (70.5%), inpatient (16.3%), or ICU (13.2%) settings. 51.2% reported subjective improvement (sliding scale scores of 67-100) since long-COVID onset. Ages 18-29 reported significantly higher subjective status scores. Subjective status scores were unaffected by severity. 102 respondents were >12 months from their initial COVID-19 diagnosis and were tracked for longitudinal symptom persistence. All symptoms tracked had variance (mean fraction 0.58, range 0.34-0.75) in the reported symptoms at the time of long-COVID presentation when compared with patient survey report. 48 reported persistent dyspnea, 23 (48%) had resolved it at time of survey. For fatigue, 44 had persistence, 12 (27%) resolved. Interpretation: Overall, 51.2% respondents improved since their long-COVID began. Pulmonary symptoms were more persistent than neuromuscular symptoms (anosmia, dysgeusia, myalgias). Gender, time since acute COVID infection, and its severity didn't affect subjective status or symptoms. This study highlights recall bias that may be prevalent in other long-COVID research reliant on participant memory.

Audio long read: Long COVID is a double curse in low-income nations — here's why

Audio long read: Why loneliness is bad for your health

Long covid—mechanisms, risk factors, and management

Long COVID research in minority ethnic populations may be lost in translation

Attributes and predictors of long COVID

Prevalence of Long-COVID Among Low-Income and Marginalized Groups: Evidence From Israel

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Long-Term Effects of COVID-19: The Stories of 2 Physicians Who Became Patients

Long Covid: a global health issue - a prospective, cohort study set in four continents

The double invisibility of long Covid in children

Long Covid: Online patient narratives, public health communication and vaccine hesitancy

Pathophysiological, immunological, and inflammatory features of long COVID

The long COVID research literature

Long COVID Illness: Disparities in Understanding and Receipt of Care in Emergency Department Populations

Epidemiological and clinical perspectives of long COVID syndrome

A Comprehensive Review of the Global Epidemiology, Clinical Management, Socio-Economic Impacts, and National Responses to Long COVID with Future Research Directions

Insights into Long COVID: Unraveling Risk Factors, Clinical Features, Radiological Findings, Functional Sequelae and Correlations: A Retrospective Cohort Study

Diagnosing, Managing, and Studying Long-COVID Syndromes in Children & Adolescents in Rural and Underserved Populations

Disparities by social determinants of health: links between Long COVID and cardiovascular disease.

Understanding Health Disparities and Economic Implications in Long COVID Worldwide

Long-COVID improves in 50% of patients after a year in a Midwestern cohort